BlossomHill Therapeutics Inc.
BLSM | NASDAQ
$26.80
+$1.06 (+4.12%)
At close: Sep 21, 2026, 4:00 PM ET
$26.14
-$0.66 (-2.46%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | TTM 2025 Dec 30, 2025 | TTM 2024 Dec 30, 2024 |
|---|---|---|
PE Ratio | -7.69 | -15.09 |
PEG Ratio | -0.08 | n/a |
PS Ratio | n/a | n/a |
PB Ratio | -3.53 | -6.38 |
P/FCF Ratio | -9.70 | -14.77 |
P/OCF Ratio | -9.92 | -14.81 |
OCF/S Ratio | n/a | n/a |
Debt / Equity Ratio | -0.17 | -0.01 |
Quick Ratio | 8.97 | 15.38 |
Current Ratio | 8.97 | 15.38 |
Asset Turnover | n/a | n/a |
Interest Coverage | n/a | n/a |
Return on Equity | 45.97% | 42.12% |
Return on Assets | -37.16% | -28.75% |
Return on Invested Capital | -43.41% | -36.21% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | n/a | n/a |
Net Profit Margin | n/a | n/a |
Pretax Profit Margin | n/a | n/a |
Operating Profit Margin | n/a | n/a |
FCF Margin | n/a | n/a |
EBITDA Margin | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BLSM